Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF 2

NCT02488421 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT02488421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02488421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF 2
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
July 31, 2016
Enrollment
38,122 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation